These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3134150)

  • 1. In vivo immunopotentiating activity of thymopentin in aging humans: modulation of IL-2 receptor expression.
    Barcellini W; Meroni PL; Borghi MO; Frasca D; Perego R; Doria G; Zanussi C
    Clin Immunol Immunopathol; 1988 Aug; 48(2):140-9. PubMed ID: 3134150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo immunopotentiating activity of thymopentin in aging humans: increase of IL-2 production.
    Meroni PL; Barcellini W; Frasca D; Sguotti C; Borghi MO; De Bartolo G; Doria G; Zanussi C
    Clin Immunol Immunopathol; 1987 Feb; 42(2):151-9. PubMed ID: 3542319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro influence of thymopentin on proliferative responses and phytohemagglutinin-induced interleukin 2 production in normal human lymphocyte cultures.
    Duchateau J; Servais G; Cooman R; Collet H; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():116-24. PubMed ID: 3898283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome.
    Hamilton G; Zöch G; Rath T; Meissl G
    Prog Clin Biol Res; 1989; 308():995-9. PubMed ID: 2528748
    [No Abstract]   [Full Text] [Related]  

  • 5. Experiences with immunomodulant agents in HIV infections.
    Lazzarin A; Barcellini W; Uberti Foppa C; Borghi MO; Franzetti R; Cinque P; Moroni M
    Acta Haematol; 1987; 78 Suppl 1():84-90. PubMed ID: 3124453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a synthetic extract (thymopentin) on the immune system of lepromatous leprosy patients.
    Munno I; Pellegrino NM; Fumo G; Barbieri G; Polimeno G; de Filippis V; Jirillo E
    Cytobios; 1987; 52(210-211):167-73. PubMed ID: 3123147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stimulation of immunogenesis by neurotensin, pentagastrin and thymopentin and ways of its realization].
    Belokrylov GA; Molchanova IV; Popova OIa
    Biull Eksp Biol Med; 1989 Nov; 108(11):584-7. PubMed ID: 2699257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymopentin treatment in AIDS and pre-AIDS patients.
    Clumeck N; Cran S; Van de Perre P; Mascart-Lemone F; Duchateau J; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():58-62. PubMed ID: 3898293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro and in vivo studies with interleukin 2 (IL-2) and various immunostimulants in a patient with AIDS].
    Vaith P; Maas D; Feigl D; Hauke G; Lang B; Oepke G; Stierle HE; Bross KJ; Andreesen R; Gross G
    Immun Infekt; 1985 Apr; 13(2):51-63. PubMed ID: 2581885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of thymopentin on antibody response, and monocyte and T cell function in hemodialysis patients who fail to respond to hepatitis B vaccination.
    Dumann H; Meuer SC; Renschin G; Köhler H
    Nephron; 1990; 55(2):136-40. PubMed ID: 2194133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thymopentin and immune response in patients with cancer].
    Petronella P; Ferrone R; Freda F; Valeriani G
    Minerva Chir; 1989 Sep; 44(18):2017-20. PubMed ID: 2694011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostimulation by TP-5 in immunocompromised patients and animals--current status of investigation.
    Waymack JP; Alexander JW
    Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):225-32. PubMed ID: 3539496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic effects of long-term thymopentin treatment in patients with HIV-induced lymphadenopathy syndrome.
    Silvestris F; Gernone A; Frassanito MA; Dammacco F
    J Lab Clin Med; 1989 Feb; 113(2):139-44. PubMed ID: 2644387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of the impaired lymphocyte stimulation in old people by thymopoietin pentapeptide.
    Verhaegen H; De Cock W; De Cree J; Goldstein G
    J Clin Lab Immunol; 1981 Sep; 6(2):103-5. PubMed ID: 7026790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy.
    Barcellini W; Meroni PL; Frasca D; Sguotti C; Borghi MO; Uberti-Foppa C; Buzzetti P; Lazzarin A; Doria G; Moroni M
    Clin Exp Immunol; 1987 Mar; 67(3):537-43. PubMed ID: 3301099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo enhancement of NK-cell activity by thymopentin.
    Hu C; Radelli L; Scorza R; Bonara P; Perego R; Fantuzzi G
    Int J Immunopharmacol; 1990; 12(2):193-7. PubMed ID: 2184134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of immune response in aged humans through different administration modes of thymopentin.
    Duchateau J; Servais G; Vreyens R; Delespesse G; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():94-101. PubMed ID: 3898299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immune-enhancing effect of perioperative thymopentin administration in elderly patients undergoing major surgery.
    Faist E; Ertel W; Salmen B; Weiler A; Ressel C; Bolla K; Heberer G
    Arch Surg; 1988 Dec; 123(12):1449-53. PubMed ID: 3056331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymopentin as adjuvant in non-responders or hyporesponders to hepatitis B vaccination.
    Záruba K; Rastorfer M; Grob PJ; Joller-Jemelka H; Bolla K
    Lancet; 1983 Nov; 2(8361):1245. PubMed ID: 6139582
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary results on clinical and immunological effects of thymopentin in AIDS.
    Clumeck N; van de Perre P; Mascart-Lemone F; Cran S; Bolla K; Duchateau J
    Int J Clin Pharmacol Res; 1984; 4(6):459-63. PubMed ID: 6398315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.